Page 5 - Diagnostics Segment News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Diagnostics segment. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Diagnostics Segment Today - Breaking & Trending Today

Thermo Fisher Scientific Reports First Quarter 2021 Results


Thermo Fisher Scientific Reports First Quarter 2021 Results
News provided by
Share this article
Share this article
WALTHAM, Mass., April 29, 2021 /PRNewswire/  Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the first quarter ended April 3, 2021.
First Quarter 2021 Highlights
First quarter GAAP diluted earnings per share (EPS) increased 198% to $5.88.
First quarter adjusted EPS increased 145% to $7.21.
Continued significant role in enabling the COVID-19 response, helping to scale vaccine production and supporting testing globally, and accelerated growth in the base business.
Strong start to the year in terms of product launches including two Thermo Scientific Orbitrap Exploris Gas Chromatography-Mass Spectrometers, which bring high-resolution analysis to a range of applications, including toxicology and metabolomics, the Thermo Scientific Spectra Ultra electron micro ....

United States , Marcn Casper , Rafael Tejada , Life Sciences Solutions , Unity Lab Services , Services Segment , Ppd Inc , Thermo Fisher , Life Sciences Solutions Segment , Mesa Biotech Inc , Exchange Rate Effect On Cash , Thermo Fisher Scientific Inc , Fisher Scientific , Our Mission , Laboratory Products , Thermo Fisher Scientific , Thermo Scientific Spectra Ultra , Kingfisher Apex Purification System , Thermo Scientific Aerosolsense Sampler , North America , Mesa Biotech , Sciences Solutions Segment , Instruments Segment , Diagnostics Segment , Thermo Scientific , Applied Biosystems ,

Minneapolis-based Bio-Techne buying Texas company for at least $215M

Minneapolis-based Bio-Techne buying Texas company for at least $215M
startribune.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from startribune.com Daily Mail and Mail on Sunday newspapers.

United States , Chuck Kummeth , Matt Mcmanus , Bio Techne Corp , Diagnostics Segment , ஒன்றுபட்டது மாநிலங்களில் , மேட் மக்ம்யாநஸ் , உயிர் தொழில்நுட்பம் கார்ப் , பரிசோதனை பிரிவு ,

Bio-Techne to Acquire Asuragen


Share this article
Share this article
MINNEAPOLIS and AUSTIN, Texas, March 3, 2021  /PRNewswire/ Bio-Techne Corporation (NASDAQ: TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities, today announced it has reached an agreement to acquire Asuragen, Inc. for initial consideration of $215 million in cash plus contingent consideration of up to $105 million upon the achievement of certain future milestones.  The transaction will be financed through a combination of cash on hand and an existing revolving line of credit.  Bio-Techne anticipates the acquisition to close in the fourth quarter of its fiscal 2021.
Founded in 2006, Asuragen is headquartered in Austin, Texas and is a leader in the development, manufacturing and commercialization of genetic carrier screening and oncology testing kits.  Asuragen s products leverage proprietary chemistries which can be used on widely availabl ....

United States , Chuck Kummeth , David Clair , Fredrickson Byron , Lynne Hohlfeld , Matt Mcmanus , Exchange Commission , Prnewswire Bio Techne Corporation , American College Of Obstetricians , Corporate Development , Asuragen Inc , Vinson Elkins , Bio Techne Corporation , Techne Corporation , Good Manufacturing Practice , Chief Executive Officer , Fragilex Diagnostic , Carrier Screening , American College , Diagnostics Segment , Exosome Diagnostics , Perella Weinberg Partners , Looking Statements , Private Securities Litigation Reform , Senior Director , Investor Relations ,